Article metrics

Download PDFPDF

Extended report
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study

 

Online download statistics by month:

Online download statistics by month: August 2017 to May 2022

AbstractFullPdf
Aug 201713411344436
Sep 2017740790376
Oct 2017857883364
Nov 2017477479260
Dec 2017417417112
Jan 2018276277112
Feb 201834633876
Mar 2018334330117
Apr 201830230284
May 201826927187
Jun 201827527591
Jul 201821421478
Aug 201822322389
Sep 201818318379
Oct 201821121192
Nov 2018227227102
Dec 201821821889
Jan 201912812068
Feb 201915815369
Mar 2019167165104
Apr 201915715685
May 201914914977
Jun 201911711887
Jul 201916015575
Aug 201915714594
Sep 201912211069
Oct 2019162146105
Nov 201914614285
Dec 201916215385
Jan 202011811267
Feb 202011411458
Mar 202011611662
Apr 2020135136126
May 2020115115101
Jun 2020939391
Jul 202010210179
Aug 2020838193
Sep 20209290100
Oct 202013013091
Nov 202012812684
Dec 202010510570
Jan 202111111173
Feb 2021969667
Mar 2021808092
Apr 2021888862
May 202110410274
Jun 2021797974
Jul 2021666653
Aug 2021767667
Sep 2021848372
Oct 20219999100
Nov 2021909074
Dec 2021767675
Jan 2022576748
Feb 20229410180
Mar 202213013994
Apr 2022697756
May 202211111896
Total11536115615926